D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 79 Citations 17,861 311 World Ranking 12560 National Ranking 422

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Internal medicine
  • Cancer

Internal medicine, Endocrinology, Ovarian cancer, Metastasis and Cancer stem cell are his primary areas of study. Internal medicine is often connected to In vitro in his work. Jock K. Findlay combines subjects such as Paracrine signalling and Folliculogenesis with his study of Endocrinology.

His biological study spans a wide range of topics, including Epithelial–mesenchymal transition and Cancer research. The Epithelial–mesenchymal transition study combines topics in areas such as Stem cell and Oncology. His study explores the link between Metastasis and topics such as Chemotherapy that cross with problems in Immunophenotyping.

His most cited work include:

  • The establishment and maintenance of pregnancy using in vitro fertilization and embryo donation in a patient with primary ovarian failure (507 citations)
  • An update on the roles of inhibin, activin, and follistatin as local regulators of folliculogenesis. (383 citations)
  • TGF-β superfamily expression and actions in the endometrium and placenta (298 citations)

What are the main themes of his work throughout his whole career to date?

Jock K. Findlay mainly investigates Internal medicine, Endocrinology, Folliculogenesis, Ovary and Cell biology. As part of one scientific family, Jock K. Findlay deals mainly with the area of Internal medicine, narrowing it down to issues related to the Follicular fluid, and often Ovariectomized rat. All of his Endocrinology and Follicle-stimulating hormone, Follicular phase, Ovulation, Ovarian follicle and Estrous cycle investigations are sub-components of the entire Endocrinology study.

His Folliculogenesis research is multidisciplinary, relying on both Follicle, Andrology, Oocyte, Oogenesis and Reproductive technology. The concepts of his Ovary study are interwoven with issues in Estrogen and Germ cell. His study looks at the relationship between Cell biology and topics such as Endometrium, which overlap with Blastocyst and Menstrual cycle.

He most often published in these fields:

  • Internal medicine (72.73%)
  • Endocrinology (63.91%)
  • Folliculogenesis (21.49%)

What were the highlights of his more recent work (between 2011-2021)?

  • Cancer stem cell (28.10%)
  • Ovarian cancer (31.13%)
  • Cancer research (21.49%)

In recent papers he was focusing on the following fields of study:

The scientist’s investigation covers issues in Cancer stem cell, Ovarian cancer, Cancer research, Internal medicine and Metastasis. His Cancer stem cell study integrates concerns from other disciplines, such as Ovarian carcinoma, Epithelial–mesenchymal transition, Embryonic stem cell and Transplantation. His study in Ovarian cancer is interdisciplinary in nature, drawing from both In vivo and Paclitaxel, Chemotherapy, Cisplatin.

His Cancer research study incorporates themes from Cell cycle and Pathology. His work carried out in the field of Internal medicine brings together such families of science as Endocrinology and Oncology. He works mostly in the field of Endocrinology, limiting it down to topics relating to Cell biology and, in certain cases, In vitro.

Between 2011 and 2021, his most popular works were:

  • Short-term single treatment of chemotherapy results in the enrichment of ovarian cancer stem cell-like cells leading to an increased tumor burden (144 citations)
  • Short-term single treatment of chemotherapy results in the enrichment of ovarian cancer stem cell-like cells leading to an increased tumor burden (144 citations)
  • Short-term single treatment of chemotherapy results in the enrichment of ovarian cancer stem cell-like cells leading to an increased tumor burden (144 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Internal medicine
  • Cancer

Jock K. Findlay mainly focuses on Cancer stem cell, Ovarian cancer, Metastasis, Cancer research and Stem cell. Jock K. Findlay regularly links together related areas like Ovarian carcinoma in his Cancer stem cell studies. His Ovarian carcinoma research is multidisciplinary, incorporating perspectives in Tumor progression and Stem cell marker.

His Metastasis study combines topics from a wide range of disciplines, such as Paclitaxel and Chemotherapy. Jock K. Findlay has researched Stem cell in several fields, including Epithelial–mesenchymal transition, Systemic administration, Oncology and After treatment, Internal medicine. His Apoptosis research incorporates themes from Endocrinology and Cell biology.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

The establishment and maintenance of pregnancy using in vitro fertilization and embryo donation in a patient with primary ovarian failure

Peter Lutjen;Alan Trounson;John Leeton;Jock Findlay.
Nature (1984)

827 Citations

An update on the roles of inhibin, activin, and follistatin as local regulators of folliculogenesis.

Jock K. Findlay.
Biology of Reproduction (1993)

578 Citations

TGF-β superfamily expression and actions in the endometrium and placenta

Rebecca L Jones;Rebecca L Jones;Chelsea Stoikos;Jock K Findlay;Lois A Salamonsen.
Reproduction (2006)

500 Citations

Cloning and sequence analysis of cDNA species coding for the two subunits of inhibin from bovine follicular fluid.

R G Forage;J M Ring;R W Brown;B V McInerney.
Proceedings of the National Academy of Sciences of the United States of America (1986)

372 Citations

A model for follicle selection and the determination of ovulation rate in the ewe

RJ Scaramuzzi;NR Adams;DT Baird;BK Campbell.
Reproduction, Fertility and Development (1993)

360 Citations

Cross talk of signals between EGFR and IL-6R through JAK2/STAT3 mediate epithelial-mesenchymal transition in ovarian carcinomas.

M Colomiere;A C Ward;C Riley;M K Trenerry.
British Journal of Cancer (2009)

359 Citations

Angiogenesis in reproductive tissues.

J. K. Findlay.
Journal of Endocrinology (1986)

340 Citations

Epithelial mesenchymal transition and cancer stem cell-like phenotypes facilitate chemoresistance in recurrent ovarian cancer.

Nuzhat Ahmed;Khalid Abubaker;Jock Findlay;Jock Findlay;Jock Findlay;Michael Quinn.
Current Cancer Drug Targets (2010)

260 Citations

An age-related ovarian phenotype in mice with targeted disruption of the Cyp 19 (aromatase) gene.

Kara L. Britt;Ann E. Drummond;Victoria A. Cox;Mitzilee Dyson.
Endocrinology (2000)

256 Citations

Effects of bovine inhibin, transforming growth factor-β and bovine activin-A on granulosa cell differentiation

Laura A. Hutchinson;Jock K. Findlay;Fiona L. de Vos;David M. Robertson.
Biochemical and Biophysical Research Communications (1987)

253 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Jock K. Findlay

Iain J. Clarke

Iain J. Clarke

University of Melbourne

Publications: 110

Lois A. Salamonsen

Lois A. Salamonsen

Monash University

Publications: 84

David Robertson

David Robertson

Vanderbilt University

Publications: 74

Teresa K. Woodruff

Teresa K. Woodruff

Northwestern University

Publications: 74

Nigel P. Groome

Nigel P. Groome

Oxford Brookes University

Publications: 59

Wylie Vale

Wylie Vale

Salk Institute for Biological Studies

Publications: 52

Felice Petraglia

Felice Petraglia

University of Florence

Publications: 51

Henry G. Burger

Henry G. Burger

Hudson Institute of Medical Research

Publications: 48

Peter C.K. Leung

Peter C.K. Leung

University of British Columbia

Publications: 44

D. M. de Kretser

D. M. de Kretser

Monash University

Publications: 40

Alan S. McNeilly

Alan S. McNeilly

University of Edinburgh

Publications: 40

Martin M. Matzuk

Martin M. Matzuk

Baylor College of Medicine

Publications: 33

Aaron J. W. Hsueh

Aaron J. W. Hsueh

Stanford University

Publications: 31

Shunichi Shimasaki

Shunichi Shimasaki

University of California, San Diego

Publications: 30

Jodi A. Flaws

Jodi A. Flaws

University of Illinois at Urbana-Champaign

Publications: 30

Richard A. Anderson

Richard A. Anderson

University of Edinburgh

Publications: 24

Trending Scientists

Paulo Veríssimo

Paulo Veríssimo

King Abdullah University of Science and Technology

Andrew Schotter

Andrew Schotter

New York University

Thomas K. Bauer

Thomas K. Bauer

Ruhr University Bochum

Kandler Smith

Kandler Smith

National Renewable Energy Laboratory

Scott R. Watterson

Scott R. Watterson

ICON Health & Fitness, Inc.

Laurence R. Rilett

Laurence R. Rilett

University of Nebraska–Lincoln

Barbara Brodsky

Barbara Brodsky

Tufts University

Laurent M. Matuana

Laurent M. Matuana

Michigan State University

N. Thompson Hobbs

N. Thompson Hobbs

Colorado State University

Michael Gooding

Michael Gooding

Aberystwyth University

Tomio Takeuchi

Tomio Takeuchi

Keio University

Caroline H. Lear

Caroline H. Lear

Cardiff University

Anthony J. Dore

Anthony J. Dore

University of Manchester

Barry R. Schlenker

Barry R. Schlenker

University of Florida

Jeffrey L. Edleson

Jeffrey L. Edleson

University of California, Berkeley

Timo Kuosmanen

Timo Kuosmanen

Aalto University

Something went wrong. Please try again later.